11-110136669-G-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_033390.2(ZC3H12C):​c.28G>A​(p.Gly10Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000962 in 1,611,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000071 ( 0 hom. )

Consequence

ZC3H12C
NM_033390.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.12

Publications

5 publications found
Variant links:
Genes affected
ZC3H12C (HGNC:29362): (zinc finger CCCH-type containing 12C) Predicted to enable endoribonuclease activity and mRNA binding activity. Predicted to be involved in RNA phosphodiester bond hydrolysis, endonucleolytic. Predicted to be active in cytoplasmic ribonucleoprotein granule and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
RDX (HGNC:9944): (radixin) Radixin is a cytoskeletal protein that may be important in linking actin to the plasma membrane. It is highly similar in sequence to both ezrin and moesin. The radixin gene has been localized by fluorescence in situ hybridization to 11q23. A truncated version representing a pseudogene (RDXP2) was assigned to Xp21.3. Another pseudogene that seemed to lack introns (RDXP1) was mapped to 11p by Southern and PCR analyses. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
RDX Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 24
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.021260887).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZC3H12CNM_033390.2 linkc.28G>A p.Gly10Arg missense_variant Exon 2 of 6 ENST00000278590.8 NP_203748.1 Q9C0D7-1
ZC3H12CNM_001411037.1 linkc.31G>A p.Gly11Arg missense_variant Exon 2 of 6 NP_001397966.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZC3H12CENST00000278590.8 linkc.28G>A p.Gly10Arg missense_variant Exon 2 of 6 2 NM_033390.2 ENSP00000278590.3 Q9C0D7-1
ZC3H12CENST00000528673.5 linkc.31G>A p.Gly11Arg missense_variant Exon 2 of 6 2 ENSP00000431821.1 Q9C0D7-2
ZC3H12CENST00000453089.2 linkc.-66G>A 5_prime_UTR_variant Exon 1 of 5 2 ENSP00000413094.2 E9PP00
RDXENST00000645527.1 linkn.*251-4939C>T intron_variant Intron 15 of 18 ENSP00000496121.1 A0A2R8Y7M3

Frequencies

GnomAD3 genomes
AF:
0.000342
AC:
52
AN:
152108
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000821
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000122
AC:
30
AN:
245516
AF XY:
0.0000976
show subpopulations
Gnomad AFR exome
AF:
0.000905
Gnomad AMR exome
AF:
0.000117
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000541
Gnomad OTH exome
AF:
0.000335
GnomAD4 exome
AF:
0.0000706
AC:
103
AN:
1459064
Hom.:
0
Cov.:
31
AF XY:
0.0000607
AC XY:
44
AN XY:
725448
show subpopulations
African (AFR)
AF:
0.000869
AC:
29
AN:
33388
American (AMR)
AF:
0.000135
AC:
6
AN:
44390
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25966
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39670
South Asian (SAS)
AF:
0.0000468
AC:
4
AN:
85544
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.0000441
AC:
49
AN:
1110738
Other (OTH)
AF:
0.000249
AC:
15
AN:
60250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000342
AC:
52
AN:
152226
Hom.:
0
Cov.:
32
AF XY:
0.000322
AC XY:
24
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.000819
AC:
34
AN:
41516
American (AMR)
AF:
0.000720
AC:
11
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68028
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000158
Hom.:
0
Bravo
AF:
0.000408
ESP6500AA
AF:
0.000796
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000124
AC:
15
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 01, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.28G>A (p.G10R) alteration is located in exon 2 (coding exon 2) of the ZC3H12C gene. This alteration results from a G to A substitution at nucleotide position 28, causing the glycine (G) at amino acid position 10 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
18
DANN
Benign
0.89
DEOGEN2
Benign
0.016
T;.
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.0044
T
MetaRNN
Benign
0.021
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.11
N;.
PhyloP100
1.1
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.45
N;N
REVEL
Benign
0.062
Sift
Benign
0.045
D;D
Sift4G
Benign
0.91
T;T
Polyphen
0.0020
B;.
Vest4
0.28
MutPred
0.50
Loss of sheet (P = 0.0181);.;
MVP
0.043
MPC
0.037
ClinPred
0.0063
T
GERP RS
2.4
Varity_R
0.094
gMVP
0.42
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201314969; hg19: chr11-110007394; API